about
Overcoming blood shortages: red blood cell and platelet substitutes and membrane modificationsAspirin resistance for cliniciansPRV-1 mRNA expression and other molecular markers in polycythemia rubra veraPathogenesis and management of bleeding in essential thrombocythemia and polycythemia veraADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndromeDe novo and acquired forms of alpha thalassemiaPegfilgrastim use during chemotherapy: current and future applications.Whole-blood donation: blood donor suitability and adverse events.Long-term, secondary treatment of deep venous thrombosis: do we know the appropriate duration of treatment or therapeutic regimen?New anticoagulants and their potential impact on the treatment of thromboembolic disease.Cancer and thrombosis.Shifting guidelines for myeloid growth factors: applications in cancer chemotherapy.Phage display tools for blood typing.Recombinant factor VIIa: a universal hemostatic agent?Challenges in the development of platelet growth factors: low expectations for low counts.Pathogenesis of thrombotic thrombocytopenic purpura.Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?Laboratory diagnosis of immune heparin-induced thrombocytopenia.Platelet substitutes in the management of thrombocytopenia.Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults.Hemostatic complications associated with paraproteinemias.Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.Splenectomy in immune thrombocytopenic purpura: recent controversies and long-term outcomes.Platelet bleeding disorders and approach to their management.Thrombopoietic growth factors and cytokines.Thrombocytopenia in dengue fever.HIV Infection and thrombocytopenia.Post-transfusion purpura.The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura.Evaluation and management of bleeding during cardiac surgery.Biologic aspects of thrombopoietins and the development of therapeutic agents.A new horizon for the treatment of heparin-induced thrombocytopenia?Treating thrombocytopenia with pathogen-reduced platelets.Flow cytometry for the diagnosis of autoimmune thrombocytopenia.Methods for counting platelets in severe thrombocytopenia.Platelet transfusions in infants with necrotizing enterocolitis.The treatment of immune thrombocytopenic purpura in children.Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.Gene therapy for the hemoglobin disorders.A contemporary approach to the diagnosis and management of polycythemia vera.
P1433
Q28167259-6A0D54FF-58FE-4F28-B6C1-69D3A7A6EB69Q28168262-67FC7C7A-214A-4550-BF92-37F6E88952CBQ28191793-3C9E7815-3D0D-465B-A1F3-51BCECEDB6DBQ28212130-88B7DD1C-1A6A-4E11-8F51-A4FF96EA8921Q28248005-E06A7FA1-9FE8-4A19-948B-16653B3F2FA9Q28301957-60EDCD5D-2236-4BA5-AD4B-7BB382985C66Q30434880-C261A9D1-D70B-4EED-A497-F4E8543620A9Q33151973-07A6244A-B06C-4D68-A68F-1EE2B2388307Q33206333-65839959-2C9D-4BCC-86AA-23500E7FD903Q33206335-E7047065-1731-4AB5-AC4C-DD67D126E0FFQ33222587-2CA5B45B-C46A-48C9-8EC6-F802B463F1EBQ33225435-0161209B-E2D0-43F9-AD6A-F046B1412C2AQ33225436-40755119-ED94-4129-BA0C-0211E772BCE2Q33349301-E7E95CA4-4E38-4FC5-BC7A-C51B146F9FDAQ33349306-72A429C4-58E4-42D7-B068-C8903FE683A0Q33349309-A579965E-F8A6-43E0-9D27-C1B50C9DD6ABQ33349313-09D5F727-3034-495F-8E29-CA5ADCABF818Q33349315-C046C120-B42A-49A9-9431-CE981DCBFA12Q33349317-EFBD8C32-E383-494E-BCC6-370FDB28A906Q33349624-3A6BB2F4-B79C-4604-8604-4659ECB6C77DQ33349627-21783DD1-F241-4DA8-8C67-8EB0A14785B7Q33359577-8B67A152-465F-4EFB-8FC5-49B49C9C5638Q33362394-B4CC9008-6459-4CDE-90B7-7E70209A3F71Q33365087-BAD91B67-2F1C-4842-9BE1-32E651B8BBF4Q33365089-83DCE34D-1B94-45E9-93E2-B6D0602D897BQ33365092-1BA69255-996C-44A3-A54A-C9F9070A0624Q33365095-B0EEB199-5E12-4E40-BB9B-F6E574B96035Q33365098-27CA48AD-2EA0-466A-8678-AC4472D5458CQ33365101-25534E6A-90A4-4596-A757-5776FB1A1581Q33368182-76A1A14E-ACB7-45B6-8957-6E164CA89A7FQ33368969-3320C2F9-1F86-4221-BA5C-907E0D248C74Q33370550-36D84B80-D1A3-48BB-8D72-EA56DDA8F2EAQ33370552-48745F86-CD8E-4C17-9CBF-8DC2E3870ADCQ33370556-555D11A1-D849-4745-BC84-31B2660CC949Q33370558-AEC0199A-1FBC-43FC-BACC-497C4CEDD710Q33370560-3A5F9ECC-0BB6-4E02-B3A1-A6190D89F8FCQ33370562-6A0AB3F7-3311-4258-8957-D264B59B6991Q33370564-A81CD9D4-1B0F-41D2-A20A-F7E4A45DA96CQ34220015-2A76872E-4AC3-484C-BC97-06F81AA3DC59Q34220026-25583CD0-EC4D-4EF2-B1AC-D597AD848469
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Current hematology reports
@ast
Current hematology reports
@en
Current hematology reports
@es
Current hematology reports
@nl
type
label
Current hematology reports
@ast
Current hematology reports
@en
Current hematology reports
@es
Current hematology reports
@nl
altLabel
Curr Hematol Rep
@en
Curr. Hematol. Rep.
@en
prefLabel
Current hematology reports
@ast
Current hematology reports
@en
Current hematology reports
@es
Current hematology reports
@nl
P1055
P1156
P1476
Current hematology reports
@en